HIGH POINT, N.C.–(BUSINESS WIRE)– vTv Therapeutics Inc. (Nasdaq:VTVT), a clinical-stage biopharmaceutical
company engaged in the discovery and development of new orally
administered treatments for Alzheimer’s disease and diabetes, today
announced that Company management will present a corporate overview at
the Rodman & Renshaw Global Investment Conference, sponsored by H.C.
Wainwright & Co., LLC. The company’s management will be presenting in
the Holmes I room from 9:35 to 10:00am on September 12.
A live webcast of the presentation can be accessed on the News
& Events section of the website. The webcast will be
archived for 30 days following the presentation on the company website
at www.vtvtherapeutics.com.
About vTv Therapeutics
vTv Therapeutics Inc. is a clinical-stage biopharmaceutical company
engaged in the discovery and development of orally administered small
molecule drug candidates to fill significant unmet medical needs. vTv
has a pipeline of clinical drug candidates led by programs for the
treatment of Alzheimer’s disease and Type 2 diabetes as well as
treatment of inflammatory disorders and the prevention of muscle
weakness.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160908005310/en/
Source: vTv Therapeutics Inc.
Cet article vTv Therapeutics to Present at the Rodman & Renshaw Global Investment
Conference est apparu en premier sur EEI-BIOTECHFINANCES.